# Wang Yinan

> Wang Yinan is a Series A investor at LYFE Capital. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [LYFE Capital](https://shizune.co/investors/profile/lyfe-capital-2)
- Total investments: 1
- Last investment: Apr 2022
- Lead investor: 100%
- Last updated: Aug 2026

Wang Yinan is a Series A investor at LYFE Capital. Wang Yinan is investment director of LYFE Capital.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Shenji Bio | Shenji Bio is a developer of POCT diagnostic products and tumor molecular diagnostic products. | $47.1M | Series A | Apr 11, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Lake Bleu Capital](https://shizune.co/investors/profile/lake-bleu-capital) — VC Fund, 1 deal together
- [Lenovo Star](https://shizune.co/investors/profile/lenovo-star) — VC Fund, 1 deal together
- [Sherpa Healthcare Partners](https://shizune.co/investors/profile/sherpa-venture-capital) — VC Fund, 1 deal together

## About LYFE Capital

VC Fund · Shanghai, China

LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.

4 contacts available at LYFE Capital.

| Name | Title | Profile |
| --- | --- | --- |
| James Zhao | Founder and Partner | https://shizune.co/investors/profile/james-zhao |
| Drake Yu | Founder | https://shizune.co/investors/profile/drake-yu |
| Roy Xu | CFO | https://shizune.co/investors/profile/roy-xu |
| Wang Yinan | Partner | https://shizune.co/investors/profile/wang-yinan-60b5 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### When did Wang Yinan last invest?

The most recent investment recorded for Wang Yinan closed in Apr 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co